Skip to content

Apis Capital Advisors, LLC: IESC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Apis Capital Advisors, LLC on IESC, newest first. How the timeline and the estimate are built.

Apis Capital Advisors, LLC held 0 IESC shares at 2025-09-30 per its 13F-HR filed 2025-11-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -28,800 shares

    13F-HR 0001420506-25-003431 filed by Apis Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 28,800 shares
    Change vs previous 13F -9,200 shares

    3.03% of the 13F portfolio, value $8,531,424.

    13F-HR 0001420506-25-001956 filed by Apis Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 38,000 shares
    Change vs previous 13F +15,860 shares

    3.03% of the 13F portfolio, value $6,274,180.

    13F-HR 0001420506-25-001245 filed by Apis Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 22,140 shares
    Change vs previous 13F -24,060 shares

    2.96% of the 13F portfolio, value $4,449,254.

    13F-HR 0001420506-25-000597 filed by Apis Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 46,200 shares
    Change vs previous 13F not available

    6.42% of the 13F portfolio, value $9,222,444.

    13F-HR 0001420506-24-002553 filed by Apis Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).